Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-02-10 @ 8:29 AM
Study NCT ID:
NCT04263051
Status:
COMPLETED
Last Update Posted:
2025-02-05
First Post:
2020-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
P/2019/451
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None